Stem Cells
Stem Cell Therapies
Our Platform Begins with MSCs Derived from Donor Placental Tissue.
Regenerative therapy
Placental-derived MSCs have unique biological properties that allow them to promote tissue repair, regulate immune responses, and reduce inflammation, making them promising candidates for treating a wide range of chronic and degenerative diseases.
Through our state-of-the-art manufacturing facility in Uganda, we are pioneering the expansion of clinical-grade mesenchymal stem cells using advanced automated cell-processing technologies such as the CliniMACS® Prodigy system. This enables controlled, scalable, and reproducible cell production suitable for regenerative medicine applications.
Therapeutic Applications
Our stem cell platform is being developed for use in:
- Tissue repair and regeneration
- Anti-inflammatory and immune modulation therapies
- Treatment of chronic and degenerative diseases
- Advanced cell-based therapies
Cord Blood Banking Initiative
In parallel, we are establishing Africa’s first cord blood banking initiative, aimed at preserving lifesaving stem cells for future therapeutic use.
Cord blood stem cells have significant potential in the treatment of:
- Sickle cell disease
- Diabetes
- Neurological conditions
- Blood and immune system disorders
Through this platform, VAi aims to expand Africa’s capacity in regenerative medicine and ensure innovative therapies are developed and manufactured locally.